Modulation	O
of	O
mRNA	O
expression	O
of	O
a	O
novel	B-DNA
human	I-DNA
myeloid-selective	I-DNA
CCAAT/enhancer	I-DNA
binding	I-DNA
protein	I-DNA
gene	I-DNA
(	O
C/EBP	B-DNA
epsilon	I-DNA
)	O
.	O

Human	O
C/EBP	B-DNA
epsilon	I-DNA
is	O
a	O
newly	O
cloned	O
gene	O
coding	O
for	O
a	O
CCAAT/enhancer	B-protein
binding	I-protein
protein	I-protein
that	O
may	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
myeloid	O
differentiation	O
.	O

Our	O
studies	O
showed	O
that	O
levels	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
were	O
markedly	O
increased	O
in	O
NB4	B-cell_line
cells	I-cell_line
(	O
promyelocytic	B-cell_line
leukemia	I-cell_line
line	I-cell_line
)	O
,	O
because	O
they	O
were	O
induced	O
by	O
9-cis	O
retinoic	O
acid	O
(	O
9-cis	O
RA	O
)	O
to	O
differentiate	O
towards	O
granulocytes	B-cell_type
.	O

Accumulation	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
occurred	O
as	O
early	O
as	O
1	O
hour	O
after	O
exposure	O
of	O
NB4	B-cell_line
cells	I-cell_line
to	O
9-cis	O
RA	O
(	O
5	O
x	O
10	O
(	O
-7	O
)	O
mol/L	O
)	O
;	O
and	O
at	O
48	O
hours	O
,	O
levels	O
were	O
increased	O
by	O
5.1-fold	O
.	O

Dose-response	O
studies	O
showed	O
that	O
10	O
(	O
-7	O
)	O
to	O
10	O
(	O
-6	O
)	O
mol/L	O
9-cis	O
RA	O
(	O
12	O
hours	O
)	O
resulted	O
in	O
peak	O
levels	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
;	O
but	O
even	O
10	O
(	O
-10	O
)	O
mol/L	O
9-cis	O
RA	O
increased	O
levels	O
of	O
these	O
transcripts	O
.	O

NB4	B-cell_line
cells	I-cell_line
pulse-exposed	O
(	O
30	O
minutes	O
)	O
to	O
all-trans	O
retinoic	O
acid	O
(	O
ATRA	O
)	O
,	O
washed	O
,	O
and	O
cultured	O
(	O
3	O
days	O
)	O
with	O
either	O
dimethylsulfoxide	O
(	O
DMSO	O
)	O
or	O
hexamethylene	O
bisacetamide	O
(	O
HMBA	O
)	O
had	O
a	O
prominent	O
increase	O
in	O
levels	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
and	O
an	O
increase	O
in	O
granulocytic	O
differentiation	O
,	O
but	O
exposure	O
to	O
either	O
DMSO	O
or	O
HMBA	O
alone	O
had	O
no	O
effect	O
on	O
base	O
levels	O
of	O
C/EBP	O
epsilon	O
and	O
did	O
not	O
induce	O
differentiation	O
.	O

Macrophage-differentiation	O
of	O
NB4	B-cell_line
reduced	O
levels	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
.	O

Nuclear	O
run-off	O
assays	O
and	O
half-life	O
studies	O
showed	O
that	O
accumulation	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
by	O
9-cis	O
RA	O
was	O
due	O
to	O
enhanced	O
transcription	O
.	O

Furthermore	O
,	O
this	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
accumulation	O
did	O
not	O
require	O
synthesis	O
of	O
new	O
protein	B-protein
factors	I-protein
because	O
9-cis	O
RA	O
induced	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
accumulation	O
in	O
the	O
absence	O
of	O
new	O
protein	O
synthesis	O
.	O

ATRA	O
also	O
induced	O
expression	O
of	O
C/EBP	B-protein
epsilon	I-protein
protein	I-protein
in	O
NB4	B-cell_line
cells	I-cell_line
,	O
as	O
shown	O
by	O
Western	O
blotting	O
.	O

In	O
contrast	O
to	O
the	O
increase	O
of	O
C/EBP	O
epsilon	O
in	O
9-cis	O
RA-mediated	O
granulocytic	O
differentiation	O
,	O
the	O
DMSO-induced	O
differentiation	O
of	O
HL-60	B-cell_line
cells	I-cell_line
down	O
the	O
granulocytic	O
pathway	O
was	O
associated	O
with	O
an	O
initial	O
reduction	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
levels	O
.	O

In	O
summary	O
,	O
we	O
have	O
discovered	O
that	O
expression	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
is	O
markedly	O
enhanced	O
as	O
the	O
NB4	B-cell_line
promyelocytes	I-cell_line
are	O
induced	O
by	O
retinoids	O
to	O
differentiate	O
towards	O
granulocytes	B-cell_type
.	O

This	O
induction	O
of	O
C/EBP	B-RNA
epsilon	I-RNA
mRNA	I-RNA
expression	O
is	O
transcriptionally	O
mediated	O
and	O
occurs	O
in	O
the	O
absence	O
of	O
synthesis	O
of	O
additional	O
protein	B-protein
factors	I-protein
.	O

We	O
suspect	O
that	O
the	O
C/EBP	B-DNA
epsilon	I-DNA
promoter/enhancer	I-DNA
contains	O
a	O
retinoic	B-DNA
acid-response	I-DNA
element	I-DNA
that	O
is	O
directly	O
stimulated	O
by	O
retinoids	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Modulation	NULL
of	NULL
mRNA	NULL
Expression	NULL
of	NULL
a	NULL
Novel	NULL
Human	NULL
Myeloid-Selective	NULL
CCAAT/Enhancer	NULL
Binding	NULL
Protein	NULL
Gene	NULL
(	NULL
C/EBPe	NULL
)	NULL
By	NULL
Doris	NULL
Y.	NULL
Chih	NULL
,	NULL
Alexey	NULL
M.	NULL
Chumakov	NULL
,	NULL
Dorothy	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
Agnes	NULL
G.	NULL
Silla	NULL
,	NULL
and	NULL
H.	NULL
Phillip	NULL
Koeffler	NULL
Human	NULL
C/EBPe	NULL
is	NULL
a	NULL
newly	NULL
cloned	NULL
gene	NULL
coding	NULL
for	NULL
a	NULL
CCAAT/	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Our	NULL
studies	NULL
showed	NULL
that	NULL
levels	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
were	NULL
markedly	NULL
increased	NULL
in	NULL
NB4	NULL
cells	NULL
(	NULL
promyelocytic	NULL
leukemia	NULL
line	NULL
)	NULL
,	NULL
because	NULL
they	NULL
were	NULL
induced	NULL
by	NULL
9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
9-cis	NULL
RA	NULL
)	NULL
to	NULL
differentiate	NULL
towards	NULL
granulocytes	NULL
.	NULL

Accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
occurred	NULL
as	NULL
early	NULL
as	NULL
1	NULL
hour	NULL
after	NULL
exposure	NULL
of	NULL
NB4	NULL
cells	NULL
to	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
;	NULL
and	NULL
at	NULL
48	NULL
hours	NULL
,	NULL
levels	NULL
were	NULL
increased	NULL
by	NULL
5.1-fold	NULL
.	NULL

Dose-response	NULL
studies	NULL
showed	NULL
that	NULL
10~	NULL
'	NULL
to	NULL
10~°	NULL
mol/L	NULL
9-cis	NULL
RA	NULL
(	NULL
12	NULL
hours	NULL
)	NULL
resulted	NULL
in	NULL
peak	NULL
levels	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
;	NULL
but	NULL
even	NULL
10~	NULL
``	NULL
°	NULL
mol/L	NULL
9-cis	NULL
RA	NULL
increased	NULL
levels	NULL
of	NULL
these	NULL
transcripts	NULL
.	NULL

NB4	NULL
cells	NULL
pulse-exposed	NULL
(	NULL
30	NULL
minutes	NULL
)	NULL
to	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
ATRA	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
cultured	NULL
(	NULL
3	NULL
days	NULL
)	NULL
with	NULL
either	NULL
dimethylsulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
or	NULL
hexamethylene	NULL
bisacetamide	NULL
(	NULL
HMBA	NULL
)	NULL
had	NULL
a	NULL
prominent	NULL
increase	NULL
in	NULL
levels	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
but	NULL
exposure	NULL
to	NULL
either	NULL
DMSO	NULL
or	NULL
HMBA	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
base	NULL
levels	NULL
of	NULL
C/EBPe	NULL
and	NULL
did	NULL
not	NULL
induce	NULL
differentiation	NULL
.	NULL

Macrophage-differentiation	NULL
of	NULL
NB4	NULL
reduced	NULL
levels	NULL
of	NULL
C/EBPe	NULL
EMATOPOIETIC	NULL
CELLS	NULL
committed	NULL
to	NULL
the	NULL
myeloid	NULL
lineage	NULL
progress	NULL
through	NULL
a	NULL
complex	NULL
series	NULL
of	NULL
differentiation	NULL
steps	NULL
before	NULL
reaching	NULL
the	NULL
morphologically	NULL
and	NULL
functionally	NULL
distinct	NULL
end-stage	NULL
of	NULL
macrophages	NULL
and	NULL
neutrophils	NULL
.	NULL

While	NULL
differentiating	NULL
,	NULL
these	NULL
cells	NULL
are	NULL
continually	NULL
reprogrammed	NULL
to	NULL
express	NULL
stage-specific	NULL
genes	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
regulatory	NULL
transcription	NULL
factors	NULL
.	NULL
'	NULL

''	NULL
Consequently	NULL
,	NULL
as	NULL
studies	NULL
on	NULL
myeloid	NULL
genes	NULL
suggest	NULL
,	NULL
transcription	NULL
factors	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
myelopoiesis	NULL
and	NULL
untimely	NULL
transcriptional	NULL
activity	NULL
may	NULL
result	NULL
in	NULL
a	NULL
failure	NULL
to	NULL
differentiate	NULL
and	NULL
promote	NULL
leukemic	NULL
growth	NULL
.	NULL
``	NULL

''	NULL
To	NULL
understand	NULL
the	NULL
process	NULL
of	NULL
normal	NULL
myeloid	NULL
differentiation	NULL
,	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
important	NULL
regulatory	NULL
factors	NULL
integral	NULL
to	NULL
the	NULL
myeloid	NULL
lineage	NULL
are	NULL
important	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
a	NULL
number	NULL
of	NULL
developmental	NULL
and	NULL
growth	NULL
regulatory	NULL
processes	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
.	NULL

*	NULL
``	NULL
'	NULL
In	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
C/EBP-	NULL
«	NULL
,	NULL
-	NULL
#	NULL
,	NULL
and	NULL
-8	NULL
showed	NULL
a	NULL
coordinated	NULL
pattern	NULL
of	NULL
expression	NULL
in	NULL
differentiating	NULL
myeloid	NULL
cells	NULL
and	NULL
appeared	NULL
to	NULL
play	NULL
decisive	NULL
roles	NULL
in	NULL
myelopoiesis	NULL
.	NULL
``	NULL

These	NULL
three	NULL
C/EBP	NULL
isoforms	NULL
also	NULL
collaborated	NULL
with	NULL
the	NULL
Myb	NULL
onco-protein	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
myeloid-specific	NULL
target	NULL
genes	NULL
,	NULL
even	NULL
in	NULL
cells	NULL
of	NULL
heterologous	NULL
tissues	NULL
such	NULL
as	NULL
erythro-blasts	NULL
or	NULL
fibroblasts	NULL
.	NULL

*	NULL
Expression	NULL
of	NULL
C/EBP-/	NULL
#	NULL
was	NULL
found	NULL
to	NULL
parallel	NULL
the	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
to	NULL
macrophages	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
mice	NULL
containing	NULL
a	NULL
homozygous	NULL
null	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
or	NULL
the	NULL
C/EBP-a	NULL
«	NULL
were	NULL
found	NULL
to	NULL
be	NULL
defective	NULL
in	NULL
either	NULL
macrophage	NULL
functions	NULL
or	NULL
granulocyte	NULL
de-velopment	NULL
,	NULL
respectively	NULL
.	NULL

``	NULL
*	NULL
``	NULL
*	NULL
Another	NULL
C/EBP-like	NULL
factor	NULL
,	NULL
C/	NULL
EBP-y	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
ubiquitously	NULL
``	NULL
and	NULL
cooperated	NULL
with	NULL
Fos	NULL
to	NULL
bind	NULL
to	NULL
positive	NULL
regulatory	NULL
element-I	NULL
(	NULL
PRE-I	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
strong	NULL
enhancer	NULL
element	NULL
essential	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
interleukin-4-encoding	NULL
gene	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
isolated	NULL
another	NULL
member	NULL
of	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
C/EBPe	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
``	NULL
This	NULL
gene	NULL
has	NULL
two	NULL
exons	NULL
and	NULL
encodes	NULL
a	NULL
nuclear	NULL
phosphoprotein	NULL
of	NULL
32	NULL
kD	NULL
.	NULL
``	NULL

The	NULL
DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
C/EBPe	NULL
shows	NULL
Blood	NULL
,	NULL
Vol	NULL
90	NULL
,	NULL
No	NULL
8	NULL
(	NULL
October	NULL
15	NULL
)	NULL
,	NULL
1997	NULL
:	NULL
pp	NULL
2987-2994	NULL
mRNA	NULL
.	NULL

Nuclear	NULL
run-off	NULL
assays	NULL
and	NULL
half-life	NULL
studies	NULL
showed	NULL
that	NULL
accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
by	NULL
9-cis	NULL
RA	NULL
was	NULL
due	NULL
to	NULL
enhanced	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
C/EBPe	NULL
mRNA	NULL
accumulation	NULL
did	NULL
not	NULL
require	NULL
synthesis	NULL
of	NULL
new	NULL
protein	NULL
factors	NULL
because	NULL
9-cis	NULL
RA	NULL
induced	NULL
C/EBPe	NULL
mRNA	NULL
accumulation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

ATRA	NULL
also	NULL
induced	NULL
expression	NULL
of	NULL
C/EBPe	NULL
protein	NULL
in	NULL
NB4	NULL
cells	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
increase	NULL
of	NULL
C/EBPe	NULL
in	NULL
9-cis	NULL
RA-mediated	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
the	NULL
DMSO-induced	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
down	NULL
the	NULL
granulocytic	NULL
pathway	NULL
was	NULL
associated	NULL
with	NULL
an	NULL
initial	NULL
reduction	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
levels	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
discovered	NULL
that	NULL
expression	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
is	NULL
markedly	NULL
enhanced	NULL
as	NULL
the	NULL
NB4	NULL
promyelocytes	NULL
are	NULL
induced	NULL
by	NULL
retinoids	NULL
to	NULL
differentiate	NULL
towards	NULL
granulocytes	NULL
.	NULL

This	NULL
induction	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
expression	NULL
is	NULL
transcriptionally	NULL
mediated	NULL
and	NULL
occurs	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
synthesis	NULL
of	NULL
additional	NULL
protein	NULL
factors	NULL
.	NULL

We	NULL
suspect	NULL
that	NULL
the	NULL
C/EBPe	NULL
promoter/enhancer	NULL
contains	NULL
a	NULL
retinoic	NULL
acid-re-sponse	NULL
element	NULL
that	NULL
is	NULL
directly	NULL
stimulated	NULL
by	NULL
retinoids	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

that	NULL
the	NULL
gene	NULL
encodes	NULL
a	NULL
protein	NULL
highly	NULL
homologous	NULL
to	NULL
rat	NULL
CRP1	NULL
.	NULL
``	NULL

'	NULL
Similar	NULL
to	NULL
other	NULL
C/EBP	NULL
isoforms	NULL
,	NULL
C/EBPe	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
C/EBP	NULL
binding	NULL
site	NULL
.	NULL
``	NULL

''	NULL
Remarkably	NULL
,	NULL
C/EBPe	NULL
shows	NULL
a	NULL
restricted	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
,	NULL
especially	NULL
during	NULL
their	NULL
differentiation	NULL
toward	NULL
granulo-cytes	NULL
.	NULL
``	NULL

Expression	NULL
studies	NULL
of	NULL
this	NULL
gene	NULL
showed	NULL
that	NULL
it	NULL
is	NULL
expressed	NULL
independently	NULL
of	NULL
other	NULL
C/EBP	NULL
proteins	NULL
.	NULL

Such	NULL
a	NULL
restricted	NULL
pattern	NULL
of	NULL
expression	NULL
suggests	NULL
greatly	NULL
that	NULL
the	NULL
gene	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
myelopoiesis	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
C/EBPe	NULL
expression	NULL
during	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cells	NULL
by	NULL
culturing	NULL
several	NULL
myeloid	NULL
cell	NULL
lines	NULL
with	NULL
various	NULL
differentiating	NULL
agents	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
C/	NULL
EBPe	NULL
is	NULL
closely	NULL
associated	NULL
with	NULL
the	NULL
retinoid-mediated	NULL
differentiation	NULL
of	NULL
early	NULL
myeloid	NULL
cells	NULL
to	NULL
granulocytes	NULL
and	NULL
that	NULL
this	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
transcriptional	NULL
mechanisms	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

From	NULL
the	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Cedars-Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
December	NULL
19	NULL
,	NULL
1996	NULL
;	NULL
accepted	NULL
June	NULL
5	NULL
,	NULL
1997	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
and	NULL
also	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Concern	NULL
Foundation	NULL
and	NULL
the	NULL
Parker	NULL
Hughes	NULL
Trust	NULL
.	NULL

H.P.K	NULL
.	NULL

is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
UCLA	NULL
Jonsson	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
and	NULL
holds	NULL
an	NULL
endowed	NULL
Mark	NULL
Goodson	NULL
Chair	NULL
of	NULL
Oncology	NULL
Research	NULL
at	NULL
Cedars-Sinai	NULL
Medical	NULL
Center/UCLA	NULL
School	NULL
of	NULL
Medicine	NULL
.	NULL

D.Y.C	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Grant	NULL
(	NULL
No	NULL
.	NULL

GMO8O42	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
H.	NULL
Phillip	NULL
Koeffler	NULL
,	NULL
MD	NULL
,	NULL
Director	NULL
,	NULL
Division	NULL
of	NULL
Hematology/Oncology	NULL
,	NULL
Professor	NULL
of	NULL
Medicine	NULL
,	NULL
UCLA	NULL
,	NULL
8700	NULL
Beverly	NULL
Blvd	NULL
,	NULL
B-213	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
90048	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/97/9008-0002	NULL
$	NULL
3.00/0	NULL
2987	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2988	NULL
A	NULL
0	NULL
_	NULL
1	NULL
2	NULL
6	NULL
12	NULL
24	NULL
3	NULL
_	NULL
'	NULL
..	NULL
Fold-induction	NULL
1	NULL
1.6	NULL
1.7	NULL
3.3	NULL
3.7	NULL
4.2	NULL
5.1	NULL
CHIH	NULL
ET	NULL
AL	NULL
48	NULL
-	NULL
Hours	NULL
C/EBPE	NULL
2.1	NULL
Kb	NULL
-	NULL
...	NULL
...	NULL
.	NULL

B-actin	NULL
B	NULL
0	NULL
1041	NULL
1019	NULL
10	NULL
%	NULL
10	NULL
%	NULL
107	NULL
12km-	NULL
M	NULL
R	NULL
w	NULL
u	NULL
...	NULL
C/EBPE	NULL
Fold-induction	NULL
10	NULL
O14	NULL
1.50	NULL
3.2	NULL
3.9	NULL
510	NULL
4.5	NULL
2.1	NULL
Kb	NULL
-	NULL
.	NULL

...	NULL
a	NULL
#	NULL
.	NULL

B-actin	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
culture	NULL
conditions	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Tissue	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

NB4	NULL
cells	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
M.	NULL
Lanotte	NULL
(	NULL
St	NULL
Louis	NULL
Hospital	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
100	NULL
U/mL	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
pg/mL	NULL
streptomycin	NULL
(	NULL
GIBCO/BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
determined	NULL
in	NULL
all	NULL
experimental	NULL
procedures	NULL
using	NULL
trypan	NULL
blue	NULL
exclu-sion	NULL
.	NULL

Chemicals	NULL
.	NULL

All-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
ATRA	NULL
;	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
95	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
ethanol	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
10~	NULL
mol/L	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

9-cis	NULL
retinoic	NULL
acid	NULL
(	NULL
Q-cis	NULL
RA	NULL
;	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Dawson	NULL
,	NULL
Stanford	NULL
Research	NULL
Institute	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
95	NULL
%	NULL
ethanol	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
10~	NULL
mol/L	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

The	NULL
physiologically	NULL
active	NULL
vitamin	NULL
D	NULL
compound	NULL
,	NULL
1,25	NULL
dibhydroxyvitamin	NULL
D	NULL
;	NULL
[	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
vit	NULL
D	NULL
;	NULL
;	NULL
generously	NULL
provided	NULL
by	NULL
M.	NULL
Uskokovic	NULL
,	NULL
Hoffmann	NULL
La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
]	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
ethanol	NULL
at	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
10	NULL
*	NULL
mol/L	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

12-O-tetradecanoylphorbol	NULL
12-acetate	NULL
(	NULL
TPA	NULL
;	NULL
Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
100	NULL
%	NULL
acetone	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
10~*	NULL
mol/L	NULL
and	NULL
kept	NULL
at	NULL
-20°C	NULL
.	NULL

Dimethylsulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
and	NULL
hexamethylene	NULL
bisacetamide	NULL
(	NULL
HMBA	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Actinomycin-D	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
20	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
ethanol	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
1	NULL
mg/mL	NULL
.	NULL

Cycloheximide	NULL
(	NULL
CHX	NULL
;	NULL
106	NULL
m	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Time-response	NULL
:	NULL
C/EBPe	NULL
mRNA	NULL
expression	NULL
in	NULL
NB4	NULL
cells	NULL
cultured	NULL
with	NULL
9-cis	NULL
RA	NULL
.	NULL

Northern	NULL
blot	NULL
with	NULL
total	NULL
RNA	NULL
(	NULL
30	NULL
g/lane	NULL
)	NULL
of	NULL
NB4	NULL
exposed	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
to	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
mol/	NULL
L	NULL
)	NULL
and	NULL
probed	NULL
with	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
ethidium	NULL
bromide-staining	NULL
of	NULL
the	NULL
285	NULL
and	NULL
185	NULL
rRNA	NULL
on	NULL
the	NULL
gel	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Fold-inductions	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
densitometry	NULL
readings	NULL
of	NULL
C/EBPe	NULL
to	NULL
B-actin	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Dose-response	NULL
:	NULL
C/EBPe	NULL
mRNA	NULL
levels	NULL
in	NULL
NB4	NULL
cells	NULL
treated	NULL
with	NULL
9-cis	NULL
RA	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
30	NULL
pg/lane	NULL
)	NULL
of	NULL
NB4	NULL
cells	NULL
exposed	NULL
to	NULL
various	NULL
concentrations	NULL
of	NULL
ATRA	NULL
for	NULL
12	NULL
hours	NULL
and	NULL
hybridized	NULL
with	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
hybridization	NULL
with	NULL
the	NULL
B-actin	NULL
probe	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Fold-inductions	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
densitometry	NULL
readings	NULL
of	NULL
C/EBPe	NULL
to	NULL
B-actin	NULL
.	NULL

Sigma	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
1	NULL
%	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
GIBCO/	NULL
BRL	NULL
)	NULL
to	NULL
a	NULL
stock	NULL
concentration	NULL
of	NULL
2	NULL
mg/mL	NULL
and	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Induction	NULL
of	NULL
differentiation	NULL
.	NULL

ATRA-priming	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
the	NULL
NB4	NULL
cells	NULL
with	NULL
10~	NULL
'	NULL
mol/L	NULL
of	NULL
ATRA	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
culture	NULL
medium	NULL
without	NULL
ATRA	NULL
and	NULL
reincubated	NULL
with	NULL
various	NULL
differentiating	NULL
agents	NULL
for	NULL
3	NULL
days	NULL
.	NULL

To	NULL
stop	NULL
protein	NULL
synthesis	NULL
,	NULL
NB4	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
10	NULL
pg/mL	NULL
CHX	NULL
and	NULL
then	NULL
induced	NULL
with	NULL
5	NULL
%	NULL
10~	NULL
'	NULL
mol/L	NULL
9-cis	NULL
RA	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
RNA	NULL
stability	NULL
,	NULL
NB4	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
with	NULL
or	NULL
without	NULL
a	NULL
previous	NULL
12	NULL
hours	NULL
of	NULL
exposure	NULL
to	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
.	NULL

ATRA	NULL
and	NULL
9-cis	NULL
RA	NULL
were	NULL
used	NULL
interchangeably	NULL
because	NULL
they	NULL
had	NULL
similar	NULL
biologic	NULL
activities	NULL
.	NULL

Differentiation	NULL
of	NULL
cell	NULL
lines	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
produce	NULL
superoxide	NULL
as	NULL
measured	NULL
by	NULL
reduction	NULL
of	NULL
nitroblue	NULL
tetrazolium	NULL
(	NULL
NBT	NULL
)	NULL
and	NULL
by	NULL
analysis	NULL
of	NULL
the	NULL
membrane-bound	NULL
differentiation	NULL
marker	NULL
,	NULL
CD11b	NULL
,	NULL
using	NULL
one-	NULL
and	NULL
two-color	NULL
immunofluorescence	NULL
.	NULL

The	NULL
latter	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
60	NULL
minutes	NULL
in	NULL
10	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
(	NULL
Sigma	NULL
)	NULL
to	NULL
block	NULL
Fc	NULL
receptors	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conju-gated	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Control	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
FITC-conju-gated	NULL
mouse	NULL
IgG1	NULL
isotype	NULL
control	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
fluorescence	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometry	NULL
,	NULL
using	NULL
a	NULL
LYSIS	NULL
II	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TRANSCRIPTIONAL	NULL
CONTROL	NULL
OF	NULL
C/EBPe	NULL
Treatment	NULL
ATRA	NULL
+	NULL
TPA	NULL
Priming	NULL
1.2	NULL
Ko	NULL
-	NULL
lie	NULL
Fig	NULL
2	NULL
.	NULL

Regulation	NULL
of	NULL
C/EBPe	NULL
expression	NULL
in	NULL
NB4	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
after	NULL
ATRA-prim-ing	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
30	NULL
pg/lane	NULL
)	NULL
from	NULL
NB4	NULL
cells	NULL
treated	NULL
with	NULL
various	NULL
differentiating	NULL
agents	NULL
for	NULL
3	NULL
days	NULL
with	NULL
or	NULL
without	NULL
30	NULL
minutes	NULL
of	NULL
priming	NULL
with	NULL
1	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
ATRA	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
of	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
the	NULL
B-actin	NULL
probe	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
on	NULL
each	NULL
lane	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
Trizol	NULL
(	NULL
GIBCO/BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Twenty	NULL
to	NULL
30	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
electropho-resed	NULL
on	NULL
1.1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
MOPS	NULL
and	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
MSI	NULL
,	NULL
Westboro	NULL
,	NULL
MA	NULL
)	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Blots	NULL
were	NULL
hybridized	NULL
for	NULL
16	NULL
to	NULL
24	NULL
hours	NULL
at	NULL
42°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
5x	NULL
SSC	NULL
,	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
,	NULL
0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
100	NULL
pg/mL	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
Sigma	NULL
)	NULL
plus	NULL
3	NULL
x	NULL
10°	NULL
cpm/mL	NULL
of	NULL
the	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
after	NULL
labeling	NULL
with	NULL
«	NULL
-°P-dCTP	NULL
by	NULL
random	NULL
primer	NULL
DNA-labeling	NULL
system	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
to	NULL
a	NULL
stringency	NULL
of	NULL
0.1	NULL
%	NULL
SSC	NULL
at	NULL
65°C	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
Biomax	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Radioactive	NULL
counts	NULL
were	NULL
measured	NULL
through	NULL
Ambis	NULL
Core	NULL
Software	NULL
,	NULL
Version	NULL
4.0	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
CSPI	NULL
,	NULL
Billerica	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Fold-inductions	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
radioactive	NULL
counts	NULL
of	NULL
C/EBPe	NULL
to	NULL
B-actin	NULL
.	NULL

Nuclear	NULL
run-off	NULL
assays	NULL
.	NULL

-	NULL
For	NULL
run-on	NULL
experiments	NULL
,	NULL
nuclei	NULL
were	NULL
harvested	NULL
from	NULL
NB4	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
treatment	NULL
with	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
9-cis	NULL
RA	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
by	NULL
resus-pending	NULL
the	NULL
cells	NULL
in	NULL
1	NULL
mL	NULL
RSB	NULL
solution	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
3	NULL
mmol/L	NULL
and	NULL
adding	NULL
100	NULL
uL	NULL
of	NULL
3	NULL
%	NULL
NP-40	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

After	NULL
pelleting	NULL
at	NULL
500g	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
resuspended	NULL
at	NULL
10°	NULL
nuclei/mL	NULL
in	NULL
nuclei	NULL
storage	NULL
buffer	NULL
(	NULL
40	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mmol/L	NULL
Tris-HCl	NULL
]	NULL
[	NULL
pH	NULL
8.3	NULL
]	NULL
,	NULL
5	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
and	NULL
kept	NULL
on	NULL
ice	NULL
.	NULL

For	NULL
each	NULL
reaction	NULL
,	NULL
200	NULL
gL	NULL
of	NULL
nuclei	NULL
was	NULL
incubated	NULL
at	NULL
30°C	NULL
for	NULL
20	NULL
minutes	NULL
in	NULL
100	NULL
gL	NULL
of	NULL
run-on	NULL
assay	NULL
buffer	NULL
(	NULL
15	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
;	NULL
7.5	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
;	NULL
450	NULL
mmol/L	NULL
KCI	NULL
;	NULL
0.75	NULL
mmol/L	NULL
each	NULL
of	NULL
ATP	NULL
,	NULL
GTP	NULL
,	NULL
and	NULL
CTP	NULL
;	NULL
1	NULL
U/gL	NULL
RNasin	NULL
[	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WIJ	NULL
;	NULL
and	NULL
250	NULL
uCi	NULL
RNase-free	NULL
DNase	NULL
I	NULL
(	NULL
3	NULL
U	NULL
;	NULL
Pro-mega	NULL
)	NULL
was	NULL
then	NULL
added	NULL
and	NULL
the	NULL
reaction	NULL
was	NULL
incubated	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
30°C	NULL
.	NULL

Digestion	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
proteinase	NULL
K	NULL
was	NULL
performed	NULL
at	NULL
37°C	NULL
for	NULL
45	NULL
minutes	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
and	NULL
10	NULL
mmol/L	NULL
EDTA	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
then	NULL
extracted	NULL
,	NULL
precipitated	NULL
,	NULL
and	NULL
hydrolyzed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
run-on	NULL
labeled	NULL
transcripts	NULL
on	NULL
the	NULL
dot	NULL
blots	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
cDNA	NULL
plasmid	NULL
(	NULL
denatured	NULL
by	NULL
boiling	NULL
in	NULL
0.3	NULL
mol/L	NULL
NaQH	NULL
and	NULL
neutralized	NULL
with	NULL
60	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
and	NULL
6x	NULL
SSC	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
nitrocellulose	NULL
strip	NULL
(	NULL
MSI	NULL
)	NULL
in	NULL
a	NULL
dot	NULL
blot	NULL
apparatus	NULL
.	NULL

The	NULL
immobilized	NULL
plasmids	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
500	NULL
4L	NULL
of	NULL
filtered	NULL
6x	NULL
SSC	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
baked	NULL
and	NULL
prehybridized	NULL
as	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

For	NULL
each	NULL
reaction	NULL
,	NULL
equal	NULL
counts	NULL
of	NULL
run-on	NULL
labeled	NULL
transcripts	NULL
as	NULL
purified	NULL
by	NULL
ProbeQuant	NULL
G-50	NULL
micro-columns	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
were	NULL
hybridized	NULL
at	NULL
10°	NULL
cpm/mL	NULL
for	NULL
36	NULL
hours	NULL
at	NULL
42°C	NULL
.	NULL

Filters	NULL
were	NULL
2989	NULL
6	NULL
G8	NULL
8g	NULL
&	NULL
g	NULL
§	NULL
i	NULL
$	NULL
$	NULL
e	NULL
oe	NULL
OE	NULL
OE	NULL
E	NULL
OE	NULL
-	NULL
__	NULL
>	NULL
>	NULL
O	NULL
[	NULL
a	NULL
)	NULL
I	NULL
I	NULL
o	NULL
-o	NULL
ot	NULL
o-	NULL
o+	NULL
-	NULL
B	NULL
c-	NULL
c-	NULL
0+	NULL
C/EBP	NULL
:	NULL
2.	NULL
co	NULL
-	NULL
Wintel	NULL
ant	NULL
aie	NULL
da	NULL
hl	NULL
cat	NULL
A	NULL
A	NULL
5	NULL
cco	NULL
washed	NULL
to	NULL
a	NULL
stringency	NULL
of	NULL
0.1	NULL
%	NULL
SSC	NULL
at	NULL
55°C	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
Biomax	NULL
film	NULL
.	NULL

Fold-inductions	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
radioactive	NULL
counts	NULL
of	NULL
C/EBPe	NULL
to	NULL
B-actin	NULL
measured	NULL
through	NULL
Ambis	NULL
Core	NULL
Software	NULL
,	NULL
Version	NULL
4.0	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
CSPI	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

Samples	NULL
of	NULL
total	NULL
cell	NULL
lysate	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
were	NULL
denatured	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
%	NULL
electrophoresis	NULL
sample	NULL
buffer	NULL
(	NULL
120	NULL
mmol/L	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
4	NULL
%	NULL
SDS	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
3	NULL
%	NULL
B-mercaptoethanol	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
90°C	NULL
.	NULL

Samples	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
15	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
SDS	NULL
.	NULL
``	NULL

The	NULL
proteins	NULL
were	NULL
electroblotted	NULL
overnight	NULL
onto	NULL
Immobi-lon-P	NULL
membrane	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Purified	NULL
rabbit	NULL
polyclonal	NULL
anti-C/EBPe	NULL
antibody	NULL
(	NULL
18	NULL
pg/mL	NULL
)	NULL
``	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
previously	NULL
blocked	NULL
membrane	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
bound	NULL
antibody	NULL
was	NULL
detected	NULL
using	NULL
antirabbit	NULL
horseradish	NULL
peroxidase	NULL
antibody	NULL
conjugate	NULL
and	NULL
the	NULL
ECL	NULL
substrate	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

COS	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
human	NULL
C/EBPe	NULL
cDNA	NULL
expression	NULL
plasmid	NULL
or	NULL
empty	NULL
vector	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

RESULTS	NULL
Accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
during	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
NB4	NULL
cells	NULL
to	NULL
granulocytes	NULL
.	NULL

The	NULL
NB4	NULL
cells	NULL
differentiated	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
after	NULL
exposure	NULL
to	NULL
9-cis	NULL
RA	NULL
``	NULL
;	NULL
after	NULL
exposure	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
9-cis	NULL
RA	NULL
(	NULL
10~	NULL
``	NULL
mol/L	NULL
for	NULL
6	NULL
days	NULL
)	NULL
,	NULL
55	NULL
%	NULL
and	NULL
93	NULL
%	NULL
became	NULL
NBT	NULL
*	NULL
and	NULL
CD11b*	NULL
as	NULL
compared	NULL
with	NULL
less	NULL
than	NULL
5	NULL
%	NULL
and	NULL
less	NULL
than	NULL
10	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
control	NULL
NB4	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Increased	NULL
accumulation	NULL
(	NULL
1.6-fold	NULL
)	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
occurred	NULL
as	NULL
early	NULL
as	NULL
1	NULL
hour	NULL
after	NULL
exposure	NULL
of	NULL
the	NULL
NB4	NULL
cells	NULL
to	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
.	NULL

By	NULL
48	NULL
hours	NULL
after	NULL
induction	NULL
,	NULL
C/EBPe	NULL
mRNA	NULL
levels	NULL
were	NULL
5.1-fold	NULL
greater	NULL
than	NULL
the	NULL
baseline	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Longer	NULL
exposure	NULL
of	NULL
the	NULL
retinoid	NULL
did	NULL
not	NULL
result	NULL
in	NULL
increased	NULL
levels	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Dose-response	NULL
studies	NULL
with	NULL
NB4	NULL
cells	NULL
induced	NULL
with	NULL
9-cis	NULL
RA	NULL
showed	NULL
that	NULL
107	NULL
``	NULL
to	NULL
10~°	NULL
mol/L	NULL
9-cis	NULL
RA	NULL
(	NULL
12	NULL
hours	NULL
)	NULL
induced	NULL
peak	NULL
levels	NULL
(	NULL
5-fold	NULL
)	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
,	NULL
but	NULL
even	NULL
10~	NULL
'	NULL
mol/	NULL
L	NULL
9-cis	NULL
RA	NULL
increased	NULL
levels	NULL
of	NULL
the	NULL
transcripts	NULL
by	NULL
1.4-fold	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

Preexposure	NULL
of	NULL
NB4	NULL
cells	NULL
to	NULL
5	NULL
X	NULL
10~	NULL
'	NULL
mol/L	NULL
ATRA	NULL
for	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2990	NULL
CHIH	NULL
ET	NULL
AL	NULL
A	NULL
D	NULL
=~	NULL
:	NULL
++	NULL
©	NULL
|	NULL
3	NULL
5	NULL
-	NULL
24	NULL
48	NULL
Hours	NULL
’	NULL
-=-	NULL
’	NULL
-..=	NULL
«	NULL
-	NULL
MPO	NULL
pcDNA	NULL
B-actin	NULL
.	NULL

%	NULL
induced	NULL
€	NULL
control	NULL
Act	NULL
D	NULL
0	NULL
50	NULL
l	NULL
1.5	NULL
2	NULL
3	NULL
40	NULL
0	NULL
5	NULL
1	NULL
4.5	NULL
2	NULL
3	NULL
4	NULL
Hours	NULL
9-cis-RA	NULL
___	NULL
=	NULL
o=	NULL
o=	NULL
o=	NULL
-o-	NULL
o-	NULL
o	NULL
o	NULL
$	NULL
0	NULL
#	NULL
0	NULL
+0	NULL
4+	NULL
40	NULL
+0	NULL
O+	NULL
e	NULL
ttl	NULL
w	NULL
W	NULL
tp	NULL
.	NULL

cc	NULL
2.1	NULL
Kb	NULL
-	NULL
B-actin	NULL
C	NULL
9-cis-RA	NULL
-	NULL
0	NULL
4	NULL
O0	NULL
4	NULL
6	NULL
0	NULL
6	NULL
8	NULL
0	NULL
8	NULL
Hours	NULL
CHX	NULL
_	NULL
-	NULL
o	NULL
$	NULL
$	NULL
0	NULL
o	NULL
o	NULL
#	NULL
0	NULL
-o	NULL
#	NULL
$	NULL
1.2	NULL
Kb	NULL
-	NULL
m	NULL
Cc/EBPE	NULL
Fold-induction	NULL
1	NULL
2	NULL
0.9	NULL
2	NULL
15	NULL
0.9	NULL
2	NULL
2	NULL
08	NULL
2.7	NULL
Fig	NULL
3	NULL
.	NULL

30	NULL
minutes	NULL
potentiated	NULL
differentiation	NULL
of	NULL
NB4	NULL
by	NULL
nonreti-	NULL
than	NULL
90	NULL
%	NULL
NBT*	NULL
and	NULL
CD11b*	NULL
cells	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
noids	NULL
.	NULL
``	NULL

''	NULL
``	NULL
For	NULL
example	NULL
,	NULL
ATRA-priming	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
shown	NULL
)	NULL
.	NULL

RA-priming	NULL
alone	NULL
resulted	NULL
in	NULL
14	NULL
%	NULL
NBT*	NULL
and	NULL
31	NULL
%	NULL
and	NULL
then	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
HMBA	NULL
(	NULL
2	NULL
mmol/L	NULL
)	NULL
or	NULL
DMSO	NULL
CD11b*	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
ATRA-priming	NULL
alone	NULL
in-	NULL
(	NULL
1.25	NULL
%	NULL
,	NULL
vol/vol	NULL
)	NULL
resulted	NULL
in	NULL
greater	NULL
than	NULL
50	NULL
%	NULL
and	NULL
greater	NULL
creased	NULL
the	NULL
abundance	NULL
of	NULL
C/EBP	NULL
fourfold	NULL
after	NULL
washing	NULL
and	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TRANSCRIPTIONAL	NULL
CONTROL	NULL
OF	NULL
C/EBPe	NULL
2991	NULL
Fig	NULL
3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Rate	NULL
of	NULL
transcription	NULL
of	NULL
C/EBPe	NULL
in	NULL
untreated	NULL
NB4	NULL
cells	NULL
(	NULL
control	NULL
)	NULL
and	NULL
NB4	NULL
cells	NULL
induced	NULL
for	NULL
12	NULL
hours	NULL
with	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/	NULL
L	NULL
}	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
for	NULL
run-off	NULL
experiments	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Equivalent	NULL
counts	NULL
of	NULL
P-labeled	NULL
RNA	NULL
transcripts	NULL
were	NULL
hybridized	NULL
to	NULL
plasmids	NULL
immobilized	NULL
on	NULL
nitrocellulose	NULL
membranes	NULL
as	NULL
indicated	NULL
(	NULL
MPO	NULL
,	NULL
full-length	NULL
MPO	NULL
cDNA	NULL
in	NULL
PUC	NULL
vector	NULL
;	NULL
pcDNA	NULL
,	NULL
empty	NULL
peDNA	NULL
vector	NULL
;	NULL
C/EBP	NULL
,	NULL
full-length	NULL
C/EBPe	NULL
antisense	NULL
cDNA	NULL
in	NULL
pcDNA	NULL
vector	NULL
;	NULL
B-actin	NULL
,	NULL
3	NULL
'	NULL
UT	NULL
B-actin	NULL
in	NULL
PBR322	NULL
vector	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Half-life	NULL
of	NULL
mature	NULL
C/	NULL
EBPe	NULL
RNA	NULL
in	NULL
NB4	NULL
cells	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
30	NULL
pg/lane	NULL
)	NULL
of	NULL
NB4	NULL
cells	NULL
exposed	NULL
for	NULL
0	NULL
to	NULL
4	NULL
hours	NULL
to	NULL
actinomycin	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
with	NULL
or	NULL
without	NULL
prior	NULL
treatment	NULL
with	NULL
9-cis	NULL
RA	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effect	NULL
of	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
on	NULL
C/EBPe	NULL
RNA	NULL
expression	NULL
.	NULL

Northern	NULL
blot	NULL
with	NULL
total	NULL
RNA	NULL
(	NULL
30	NULL
pg/lane	NULL
)	NULL
of	NULL
NB4	NULL
cells	NULL
treated	NULL
either	NULL
with	NULL
10	NULL
g/mL	NULL
CHX	NULL
alone	NULL
,	NULL
with	NULL
CHX	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
and	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
,	NULL
or	NULL
with	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
alone	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
0	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
hours	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
B-actin	NULL
probe	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
on	NULL
each	NULL
lane	NULL
.	NULL

Fold-inductions	NULL
were	NULL
calculated	NULL
by	NULL
the	NULL
ratio	NULL
of	NULL
densitometry	NULL
readings	NULL
of	NULL
C/EBPe	NULL
to	NULL
B-actin	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Effect	NULL
of	NULL
ATRA	NULL
on	NULL
C/EBPe	NULL
protein	NULL
expression	NULL
in	NULL
NB4	NULL
cells	NULL
.	NULL

NB4	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
ATRA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
for	NULL
different	NULL
durations	NULL
.	NULL

Lysates	NULL
were	NULL
made	NULL
from	NULL
the	NULL
cells	NULL
and	NULL
Western	NULL
blotted	NULL
.	NULL

COS	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
human	NULL
C/EBPe	NULL
cDNA	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
+	NULL
)	NULL
or	NULL
empty	NULL
vector	NULL
(	NULL
lane	NULL
-	NULL
)	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
and	NULL
negative	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
arrow	NULL
denotes	NULL
C/EBPe	NULL
protein	NULL
as	NULL
seen	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

culturing	NULL
in	NULL
regular	NULL
medium	NULL
for	NULL
3	NULL
days	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Nonretinoids	NULL
used	NULL
alone	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
C/EBPe	NULL
transcripts	NULL
.	NULL

However	NULL
,	NULL
cells	NULL
primed	NULL
with	NULL
ATRA	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
HMBA	NULL
or	NULL
DMSO	NULL
,	NULL
both	NULL
potent	NULL
granulocytic-inducing	NULL
agents	NULL
,	NULL
``	NULL
resulted	NULL
in	NULL
a	NULL
greater	NULL
than	NULL
8-	NULL
to	NULL
10-fold	NULL
increase	NULL
in	NULL
C/EBP	NULL
transcript	NULL
level	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
TPA	NULL
and	NULL
vitamin	NULL
D	NULL
;	NULL
induced	NULL
NB4	NULL
cells	NULL
to	NULL
differentiate	NULL
down	NULL
the	NULL
monocytic	NULL
pathway	NULL
.	NULL
``	NULL

NB4	NULL
cells	NULL
pulsed	NULL
with	NULL
ATRA	NULL
for	NULL
30	NULL
minutes	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
TPA	NULL
(	NULL
5	NULL
X	NULL
10~°	NULL
mol/L	NULL
)	NULL
or	NULL
vit	NULL
D	NULL
;	NULL
(	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
for	NULL
3	NULL
days	NULL
became	NULL
adherent	NULL
(	NULL
>	NULL
90	NULL
%	NULL
and	NULL
>	NULL
80	NULL
%	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
as	NULL
consistent	NULL
with	NULL
monocytic	NULL
differentiation	NULL
.	NULL

ATRA-primed	NULL
cells	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
5	NULL
x	NULL
10~°	NULL
mol/L	NULL
)	NULL
or	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
107	NULL
mol/L	NULL
)	NULL
for	NULL
3	NULL
days	NULL
showed	NULL
an	NULL
approximately	NULL
10-fold	NULL
reduction	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
levels	NULL
.	NULL

Regulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
expression	NULL
in	NULL
NB4	NULL
cells	NULL
treated	NULL
with	NULL
9-cis	NULL
RA	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
9-cis	NULL
RA	NULL
affected	NULL
C/EBPe	NULL
expression	NULL
at	NULL
the	NULL
level	NULL
of	NULL
initiation	NULL
of	NULL
transcription	NULL
,	NULL
nuclei	NULL
both	NULL
from	NULL
NB4	NULL
induced	NULL
with	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
X	NULL
10~	NULL
'	NULL
mol/	NULL
L	NULL
)	NULL
for	NULL
12	NULL
hours	NULL
and	NULL
from	NULL
untreated	NULL
NB4	NULL
(	NULL
as	NULL
control	NULL
)	NULL
were	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
run-off	NULL
transcription	NULL
assays	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
transcription	NULL
of	NULL
C/EBPe	NULL
genes	NULL
in	NULL
vivo	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
amount	NULL
of	NULL
labeled	NULL
RNA	NULL
hybridizing	NULL
to	NULL
the	NULL
full-length	NULL
C/	NULL
EBPe	NULL
cDNA	NULL
on	NULL
the	NULL
dot	NULL
blot	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
,	NULL
was	NULL
increased	NULL
more	NULL
than	NULL
threefold	NULL
in	NULL
NB4	NULL
cells	NULL
treated	NULL
with	NULL
9-cis	NULL
RA	NULL
than	NULL
the	NULL
untreated	NULL
NB4	NULL
control	NULL
cells	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
radioactive	NULL
counts	NULL
(	NULL
normalized	NULL
with	NULL
B-actin	NULL
)	NULL
.	NULL

The	NULL
half-life	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
was	NULL
measured	NULL
by	NULL
calculating	NULL
the	NULL
decay	NULL
of	NULL
RNA	NULL
accumulation	NULL
after	NULL
transcription	NULL
was	NULL
blocked	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

Cumulative	NULL
radioactive	NULL
counting	NULL
showed	NULL
that	NULL
the	NULL
half-life	NULL
of	NULL
NB4	NULL
cells	NULL
was	NULL
approximately	NULL
2	NULL
hours	NULL
in	NULL
both	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
9-cis	NULL
RA	NULL
treatment	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
C/EBPe	NULL
mRNA	NULL
induction	NULL
by	NULL
9-cis	NULL
RA	NULL
was	NULL
dependent	NULL
on	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
,	NULL
NB4	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
cycloheximide	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
9-cis	NULL
RA	NULL
(	NULL
5	NULL
X	NULL
10~	NULL
'	NULL
mol/L	NULL
for	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
hours	NULL
)	NULL
.	NULL

The	NULL
data	NULL
show	NULL
that	NULL
upregulation	NULL
of	NULL
the	NULL
C/EBPe	NULL
mRNA	NULL
by	NULL
9-cis	NULL
RA	NULL
occurred	NULL
even	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
protein	NULL
synthesis	NULL
(	NULL
Fig	NULL
3C	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
by	NULL
9-cis	NULL
RA	NULL
in	NULL
NB4	NULL
cells	NULL
is	NULL
matched	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
C/EBPe	NULL
protein	NULL
,	NULL
NB4	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
ATRA	NULL
(	NULL
5	NULL
X	NULL
107	NULL
``	NULL
mol/L	NULL
)	NULL
for	NULL
different	NULL
durations	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
lysates	NULL
were	NULL
examined	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Parallel	NULL
to	NULL
the	NULL
increase	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
,	NULL
the	NULL
C/EBPe	NULL
protein	NULL
levels	NULL
began	NULL
to	NULL
increase	NULL
by	NULL
1	NULL
hour	NULL
(	NULL
Fig	NULL
3D	NULL
)	NULL
.	NULL

The	NULL
maximum	NULL
induction	NULL
occurred	NULL
by	NULL
24	NULL
hours	NULL
(	NULL
>	NULL
5-fold	NULL
)	NULL
.	NULL

Accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
during	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
U937	NULL
cells	NULL
to	NULL
granulocytes	NULL
.	NULL

-	NULL
The	NULL
U937	NULL
cells	NULL
differentiated	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
after	NULL
exposure	NULL
to	NULL
ATRA	NULL
.	NULL
``	NULL

Radioactive	NULL
counting	NULL
showed	NULL
that	NULL
the	NULL
level	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
in	NULL
U937	NULL
cells	NULL
increased	NULL
approximately	NULL
twofold	NULL
after	NULL
48	NULL
hours	NULL
of	NULL
ATRA-induction	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
during	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
to	NULL
granulocytes	NULL
.	NULL

The	NULL
HL-60	NULL
cells	NULL
differentiated	NULL
along	NULL
the	NULL
granulocytic	NULL
pathway	NULL
after	NULL
exposure	NULL
to	NULL
DMSO	NULL
and	NULL
ATRA	NULL
.	NULL
``	NULL

For	NULL
example	NULL
,	NULL
either	NULL
ATRA	NULL
(	NULL
107	NULL
mol/L	NULL
for	NULL
5	NULL
days	NULL
)	NULL
or	NULL
DMSO	NULL
(	NULL
1.25	NULL
%	NULL
vol/vol	NULL
for	NULL
5	NULL
days	NULL
)	NULL
induced	NULL
NBT	NULL
reduction	NULL
(	NULL
>	NULL
60	NULL
%	NULL
)	NULL
of	NULL
HL-60	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
HL-60	NULL
cells	NULL
(	NULL
5	NULL
%	NULL
NBT	NULL
*	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
C/EBPe	NULL
mRNA	NULL
level	NULL
increased	NULL
approximately	NULL
twofold	NULL
by	NULL
6	NULL
hours	NULL
of	NULL
ATRA-induction	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
C/EBPe	NULL
mRNA	NULL
levels	NULL
decreased	NULL
after	NULL
2	NULL
hours	NULL
of	NULL
DMSO-induction	NULL
and	NULL
then	NULL
increased	NULL
to	NULL
baseline	NULL
levels	NULL
after	NULL
24	NULL
to	NULL
72	NULL
hours	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Promyelocytic	NULL
NB4	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
myelomonoblastic	NULL
U937	NULL
cells	NULL
were	NULL
used	NULL
to	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
C/	NULL
0	NULL
1	NULL
-_	NULL
2	NULL
6	NULL
1224	NULL
48	NULL
Hours	NULL
2k	NULL
-	NULL
UU	NULL
BR	NULL
R	NULL
R	NULL
®	NULL
W	NULL
ocsr	NULL
:	NULL
2.1	NULL
Ko	NULL
-	NULL
Hh	NULL
Hh	NULL
Hh	NULL
HBB	NULL
HD	NULL
B	NULL
=	NULL
actin	NULL
Fig	NULL
4	NULL
.	NULL

Regulation	NULL
of	NULL
C/EBPe	NULL
expression	NULL
in	NULL
U937	NULL
cells	NULL
by	NULL
ATRA	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
30	NULL
pg/lane	NULL
)	NULL
of	NULL
U937	NULL
cells	NULL
exposed	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
to	NULL
ATRA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
bottom	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2992	NULL
0	NULL
2	NULL
6	NULL
24	NULL
48	NULL
Hours	NULL
1.2	NULL
Kb	NULL
-	NULL
N	NULL
we	NULL
B2	NULL
C/EBP	NULL
:	NULL
2.1	NULL
Kb	NULL
-	NULL
t	NULL
e	NULL
aaa	NULL
e	NULL
B-actin	NULL
0	NULL
|	NULL
2	NULL
6	NULL
12	NULL
24	NULL
48	NULL
72	NULL
Hours	NULL
1.2	NULL
Kb	NULL
-	NULL
WB	NULL
O	NULL
HB	NULL
HB	NULL
2.1	NULL
Ko	NULL
-+	NULL
H	NULL
H	NULL
Hae	NULL
...	NULL
.	NULL

f-actin	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
(	NULL
A	NULL
)	NULL
Regulation	NULL
of	NULL
C/EBPe	NULL
expression	NULL
in	NULL
HL60	NULL
cells	NULL
by	NULL
ATRA	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
20	NULL
pg/lane	NULL
)	NULL
of	NULL
HL6O	NULL
cells	NULL
exposed	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
to	NULL
ATRA	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
mol/L	NULL
)	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
bottom	NULL
panel	NULL
displays	NULL
the	NULL
hybridization	NULL
with	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Regulation	NULL
of	NULL
C/	NULL
EBPe	NULL
expression	NULL
in	NULL
HL60	NULL
cells	NULL
by	NULL
DMSO	NULL
.	NULL

Northern	NULL
blot	NULL
of	NULL
total	NULL
RNA	NULL
{	NULL
20	NULL
pug/lane	NULL
)	NULL
of	NULL
HL6O0	NULL
cells	NULL
exposed	NULL
for	NULL
various	NULL
lengths	NULL
of	NULL
time	NULL
to	NULL
DMSO	NULL
(	NULL
1.25	NULL
%	NULL
)	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
full-length	NULL
C/EBPe	NULL
cDNA	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
bottom	NULL
panel	NULL
shows	NULL
the	NULL
hybridization	NULL
with	NULL
B-actin	NULL
cDNA	NULL
probe	NULL
as	NULL
assessment	NULL
of	NULL
RNA	NULL
quantities	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

EBPe	NULL
gene	NULL
during	NULL
their	NULL
differentiation	NULL
.	NULL

We	NULL
found	NULL
that	NULL
RA	NULL
treatment	NULL
increased	NULL
the	NULL
abundance	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
approximately	NULL
twofold	NULL
in	NULL
HL-60	NULL
and	NULL
U937	NULL
cells	NULL
and	NULL
approximately	NULL
fivefold	NULL
in	NULL
NB4	NULL
cells	NULL
.	NULL

Accumulation	NULL
of	NULL
C/EBP	NULL
mRNA	NULL
paralleled	NULL
the	NULL
increased	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

This	NULL
occurred	NULL
most	NULL
prominently	NULL
in	NULL
the	NULL
NB4	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
paralleled	NULL
our	NULL
data	NULL
``	NULL
``	NULL
and	NULL
the	NULL
data	NULL
of	NULL
others	NULL
``	NULL
using	NULL
fresh	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
early	NULL
,	NULL
normal	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
(	NULL
CD34*/CD33~T	NULL
)	NULL
had	NULL
very	NULL
weak	NULL
expression	NULL
of	NULL
C/EBPe	NULL
;	NULL
the	NULL
CD34	NULL
*/CD33	NULL
*	NULL
more	NULL
mature	NULL
myeloid	NULL
stem	NULL
cell	NULL
expressed	NULL
slightly	NULL
more	NULL
C/EBP	NULL
.	NULL

As	NULL
the	NULL
cells	NULL
differentiated	NULL
to	NULL
promyelocytes	NULL
,	NULL
myelocytes	NULL
,	NULL
metamye-	NULL
CHIH	NULL
ET	NULL
AL	NULL
locytes	NULL
,	NULL
and	NULL
granulocytes	NULL
,	NULL
levels	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
obtained	NULL
a	NULL
plateau	NULL
elevated	NULL
level	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
monocyte	NULL
and	NULL
macrophages	NULL
had	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
expression	NULL
;	NULL
and	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
C/EBPe	NULL
was	NULL
undetectable	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
an	NULL
important	NULL
function	NULL
for	NULL
C/EBP	NULL
at	NULL
the	NULL
myeloblast/	NULL
promyelocyte	NULL
stage	NULL
of	NULL
granulocyte	NULL
differentiation	NULL
.	NULL

Analysis	NULL
of	NULL
C/EBPe	NULL
deletional	NULL
mice	NULL
will	NULL
further	NULL
help	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
C/EBP	NULL
in	NULL
hematopoiesis	NULL
.	NULL

The	NULL
contribution	NULL
of	NULL
transcription	NULL
and	NULL
mRNA	NULL
stability	NULL
to	NULL
the	NULL
increase	NULL
in	NULL
steady-state	NULL
levels	NULL
of	NULL
C/EBPe	NULL
observed	NULL
in	NULL
retinoid-stimulated	NULL
NB4	NULL
cells	NULL
was	NULL
examined	NULL
.	NULL

Stability	NULL
of	NULL
the	NULL
C/EBPe	NULL
transcripts	NULL
as	NULL
assayed	NULL
by	NULL
measuring	NULL
the	NULL
decay	NULL
of	NULL
message	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
actinomycin	NULL
D	NULL
showed	NULL
no	NULL
change	NULL
during	NULL
9-cis	NULL
RA-mediated	NULL
differentiation	NULL
of	NULL
NB4	NULL
cells	NULL
to	NULL
granulocytes	NULL
.	NULL

Rate	NULL
of	NULL
transcription	NULL
of	NULL
the	NULL
C/EBPe	NULL
gene	NULL
was	NULL
also	NULL
measured	NULL
from	NULL
nuclei	NULL
isolated	NULL
from	NULL
both	NULL
untreated	NULL
NB4	NULL
and	NULL
NB4	NULL
cells	NULL
induced	NULL
with	NULL
9-cis	NULL
RA	NULL
.	NULL

The	NULL
retinoid	NULL
(	NULL
5	NULL
x	NULL
10~	NULL
'	NULL
mol/L	NULL
)	NULL
increased	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
of	NULL
C/EBPe	NULL
by	NULL
approximately	NULL
threefold	NULL
at	NULL
12	NULL
hours	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
observed	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

Also	NULL
,	NULL
ATRA-induction	NULL
of	NULL
NB4	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
peak	NULL
fivefold	NULL
induction	NULL
of	NULL
C/EBPe	NULL
protein	NULL
at	NULL
24	NULL
hours	NULL
,	NULL
paralleling	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
transcript	NULL
levels	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
they	NULL
stimulated	NULL
accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
is	NULL
further	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
retinoids	NULL
have	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
transcription	NULL
of	NULL
C/EBPe	NULL
.	NULL

The	NULL
enhancement	NULL
in	NULL
accumulation	NULL
of	NULL
C/EBPe	NULL
mRNA	NULL
by	NULL
retinoids	NULL
may	NULL
not	NULL
merely	NULL
be	NULL
a	NULL
reflection	NULL
of	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
because	NULL
HL-60	NULL
cells	NULL
cultured	NULL
with	NULL
DMSO	NULL
undergo	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
``	NULL
but	NULL
levels	NULL
of	NULL
C/	NULL
EBPe	NULL
mRNA	NULL
at	NULL
least	NULL
initially	NULL
decreased	NULL
rather	NULL
than	NULL
in-creased	NULL
.	NULL

These	NULL
studies	NULL
suggest	NULL
strongly	NULL
for	NULL
transcriptional	NULL
control	NULL
of	NULL
C/EBP	NULL
via	NULL
a	NULL
retinoid	NULL
acid	NULL
response	NULL
element	NULL
.	NULL

Could	NULL
the	NULL
prominent	NULL
induction	NULL
of	NULL
expression	NULL
of	NULL
C/EBP	NULL
mNRA	NULL
observed	NULL
in	NULL
NB4	NULL
be	NULL
unique	NULL
to	NULL
this	NULL
cell	NULL
type	NULL
?	NULL

The	NULL
cell	NULL
line	NULL
NB4	NULL
was	NULL
established	NULL
from	NULL
the	NULL
leukemia	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia®	NULL
``	NULL
and	NULL
the	NULL
cells	NULL
contain	NULL
the	NULL
pathognomic	NULL
chromosomal	NULL
rearrangement	NULL
1	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
resulting	NULL
in	NULL
the	NULL
PML-RAR	NULL
fusion	NULL
gene	NULL
.	NULL
``	NULL

This	NULL
PML-RAR	NULL
fusion	NULL
product	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
block	NULL
or	NULL
interfere	NULL
with	NULL
transcription	NULL
of	NULL
genes	NULL
critical	NULL
to	NULL
myeloid	NULL
differentiation	NULL
,	NULL
perhaps	NULL
by	NULL
sequestering	NULL
the	NULL
RARa	NULL
in	NULL
non-functional	NULL
locations	NULL
as	NULL
shown	NULL
by	NULL
a	NULL
nuclear	NULL
speckled	NULL
pattern	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
.	NULL
``	NULL

High	NULL
concentrations	NULL
of	NULL
retinoic	NULL
acid	NULL
allow	NULL
the	NULL
RAR	NULL
fusion	NULL
protein	NULL
to	NULL
assume	NULL
a	NULL
more	NULL
typical	NULL
RAR	NULL
nuclear	NULL
location	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
retinoid-PML/RAR	NULL
complex	NULL
more	NULL
readily	NULL
binds	NULL
and	NULL
transactivates	NULL
the	NULL
C/EBPe	NULL
gene	NULL
because	NULL
retinoids	NULL
had	NULL
only	NULL
a	NULL
moderate	NULL
enhancement	NULL
of	NULL
C/EBPe	NULL
in	NULL
HL-60	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
even	NULL
though	NULL
the	NULL
ligand	NULL
induced	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
similar	NULL
to	NULL
NB4	NULL
.	NULL

Another	NULL
explanation	NULL
for	NULL
the	NULL
prominent	NULL
effect	NULL
of	NULL
retinoids	NULL
in	NULL
NB4	NULL
could	NULL
relate	NULL
to	NULL
expression	NULL
of	NULL
other	NULL
transcriptional	NULL
factors	NULL
that	NULL
combinatori-ally	NULL
interact	NULL
with	NULL
the	NULL
RA/RAR	NULL
to	NULL
activate	NULL
C/EBPe	NULL
.	NULL

Furthermore	NULL
,	NULL
cells	NULL
that	NULL
normally	NULL
can	NULL
not	NULL
express	NULL
C/EBP	NULL
,	NULL
such	NULL
as	NULL
early	NULL
erythroblastic	NULL
K562	NULL
cells	NULL
,	NULL
can	NULL
not	NULL
be	NULL
induced	NULL
by	NULL
RA	NULL
to	NULL
express	NULL
C/EBPe	NULL
,	NULL
``	NULL
°	NULL
suggesting	NULL
that	NULL
modulation	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
the	NULL
cells	NULL
requires	NULL
more	NULL
than	NULL
retinoid	NULL
ligand	NULL
and	NULL
its	NULL
receptor	NULL
.	NULL

Further	NULL
studies	NULL
using	NULL
NB4	NULL
and	NULL
HL-60	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

TRANSCRIPTIONAL	NULL
CONTROL	NULL
OF	NULL
C/EBPe	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
resistant	NULL
to	NULL
retinoids	NULL
as	NULL
well	NULL
as	NULL
functional	NULL
analysis	NULL
of	NULL
a	NULL
potential	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
in	NULL
the	NULL
C/EBPe	NULL
gene	NULL
are	NULL
required	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Carl	NULL
W.	NULL
Miller	NULL
for	NULL
his	NULL
helpful	NULL
technical	NULL
advice	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Friedman	NULL
AD	NULL
:	NULL
Regulation	NULL
of	NULL
immature	NULL
myeloid	NULL
cell	NULL
differentiation	NULL
by	NULL
PEPB2/CBP	NULL
,	NULL
myb	NULL
,	NULL
C/EBP	NULL
and	NULL
Ets	NULL
family	NULL
members	NULL
.	NULL

Curr	NULL
Top	NULL
Microbiol	NULL
Immunol	NULL
211:149	NULL
,	NULL
1996	NULL
2	NULL
.	NULL

Zhang	NULL
DE	NULL
,	NULL
Hetherington	NULL
CJ	NULL
,	NULL
Meyers	NULL
S	NULL
,	NULL
Rhoades	NULL
KL	NULL
,	NULL
Larson	NULL
CJ	NULL
,	NULL
Chen	NULL
HM	NULL
,	NULL
Hiebert	NULL
SW	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
protein	NULL
(	NULL
C/EBP	NULL
)	NULL
and	NULL
AML1	NULL
(	NULL
CBF	NULL
alpha	NULL
2	NULL
)	NULL
synergistically	NULL
activate	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
promoter	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:1231	NULL
,	NULL
1996	NULL
3	NULL
.	NULL

Ness	NULL
SA	NULL
,	NULL
Kowenz-Leutz	NULL
E	NULL
,	NULL
Casini	NULL
T	NULL
,	NULL
Graf	NULL
T	NULL
,	NULL
Leutz	NULL
A	NULL
:	NULL
Myb	NULL
and	NULL
NF-M	NULL
:	NULL
Combinatorial	NULL
acticvators	NULL
of	NULL
myeloid	NULL
genes	NULL
in	NULL
heterologous	NULL
cell	NULL
types	NULL
.	NULL

Genes	NULL
Dev	NULL
7:749	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Simon	NULL
MC	NULL
,	NULL
Olson	NULL
M	NULL
,	NULL
Scott	NULL
E	NULL
,	NULL
Hack	NULL
A	NULL
,	NULL
Su	NULL
G	NULL
,	NULL
Singh	NULL
H	NULL
:	NULL
Terminal	NULL
myeloid	NULL
gene	NULL
expression	NULL
and	NULL
differentiation	NULL
requires	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1	NULL
.	NULL

Curr	NULL
Top	NULL
Microbiol	NULL
Immunol	NULL
211:113	NULL
,	NULL
1996	NULL
5	NULL
.	NULL

Lubbert	NULL
M	NULL
,	NULL
Herrmann	NULL
F	NULL
,	NULL
Koeffier	NULL
HP	NULL
:	NULL
Expression	NULL
and	NULL
regulation	NULL
of	NULL
myeloid-specific	NULL
genes	NULL
in	NULL
normal	NULL
and	NULL
leukemic	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
77:909	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Nichols	NULL
J	NULL
,	NULL
Nimer	NULL
SD	NULL
:	NULL
Transcriptional	NULL
factors	NULL
,	NULL
translocations	NULL
and	NULL
leukemia	NULL
.	NULL

Blood	NULL
80:2953	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Simon	NULL
TH	NULL
:	NULL
Chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
cancer	NULL
.	NULL

Nature	NULL
372:143	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Akira	NULL
S	NULL
,	NULL
Isshik	NULL
H	NULL
,	NULL
Sugita	NULL
T	NULL
,	NULL
Tanabe	NULL
O	NULL
,	NULL
Kinoshita	NULL
S	NULL
,	NULL
Nishio	NULL
Y	NULL
,	NULL
Nakajima	NULL
T	NULL
,	NULL
Hirano	NULL
T	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
9:1897	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Juan	NULL
TS	NULL
,	NULL
Wilson	NULL
DR	NULL
,	NULL
Wilde	NULL
MD	NULL
,	NULL
Darlington	NULL
GJ	NULL
:	NULL
Participation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
C/EBP	NULL
delta	NULL
in	NULL
acute-phase	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
complement	NULL
component	NULL
C3	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:2584	NULL
,	NULL
1993	NULL
10	NULL
.	NULL

Poli	NULL
V	NULL
,	NULL
Mancini	NULL
FP	NULL
,	NULL
Cortese	NULL
R	NULL
:	NULL
IL-6DBP	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
involved	NULL
in	NULL
interleukin-6	NULL
signal	NULL
transduction	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
related	NULL
to	NULL
C/EBP	NULL
.	NULL

Cell	NULL
63:643	NULL
,	NULL
1990	NULL
11	NULL
.	NULL

Wang	NULL
ND	NULL
,	NULL
Finegold	NULL
MJ	NULL
,	NULL
Bradley	NULL
A	NULL
,	NULL
Ou	NULL
CN	NULL
,	NULL
Abdelsayed	NULL
SV	NULL
,	NULL
Wilde	NULL
MD	NULL
,	NULL
Taylor	NULL
LR	NULL
,	NULL
Wilson	NULL
DR	NULL
,	NULL
Darlington	NULL
GJ	NULL
:	NULL
Impaired	NULL
energy	NULL
homeostasis	NULL
in	NULL
C/EBP	NULL
alpha	NULL
knockout	NULL
mice	NULL
.	NULL

Science	NULL
269:1108	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Scott	NULL
LM	NULL
,	NULL
Civin	NULL
CI	NULL
,	NULL
Rorth	NULL
P	NULL
,	NULL
Friedman	NULL
AD	NULL
:	NULL
A	NULL
novel	NULL
temporal	NULL
expression	NULL
pattern	NULL
of	NULL
three	NULL
C/EBP	NULL
family	NULL
members	NULL
in	NULL
differentiating	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

Blood	NULL
80:1725	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Tanaka	NULL
T	NULL
,	NULL
Akira	NULL
S	NULL
,	NULL
Yoshida	NULL
K	NULL
,	NULL
Umemoto	NULL
M	NULL
,	NULL
Yoneda	NULL
Y	NULL
,	NULL
Shirafuji	NULL
N	NULL
,	NULL
Fujiwara	NULL
H	NULL
,	NULL
Suematsu	NULL
S	NULL
,	NULL
Yoshida	NULL
N	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
NF-IL6	NULL
gene	NULL
discloses	NULL
its	NULL
essential	NULL
role	NULL
in	NULL
bacterial	NULL
killing	NULL
and	NULL
tumor	NULL
cytotoxicity	NULL
by	NULL
macrophages	NULL
.	NULL

Cell	NULL
80:353	NULL
,	NULL
1995	NULL
14	NULL
.	NULL

Zhang	NULL
DE	NULL
,	NULL
Zhang	NULL
P	NULL
,	NULL
Wang	NULL
ND	NULL
,	NULL
Hetherington	NULL
CJ	NULL
,	NULL
Darlington	NULL
GJ	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Absence	NULL
of	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
signaling	NULL
and	NULL
neutrophil	NULL
development	NULL
in	NULL
CCAAT	NULL
enhancer	NULL
binding	NULL
protein	NULL
alpha-deficient	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:569	NULL
,	NULL
1997	NULL
15	NULL
.	NULL

Roman	NULL
C	NULL
,	NULL
Platero	NULL
JS	NULL
,	NULL
Shuman	NULL
JD	NULL
,	NULL
Calame	NULL
K	NULL
:	NULL
Ig/EBP-1	NULL
:	NULL
A	NULL
ubiquitously	NULL
expressed	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
is	NULL
similar	NULL
to	NULL
C/EBP	NULL
and	NULL
heterodimerizes	NULL
with	NULL
C/EBP	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1404	NULL
,	NULL
1990	NULL
16	NULL
.	NULL

Davydov	NULL
IV	NULL
,	NULL
Bohmann	NULL
D	NULL
,	NULL
Krammer	NULL
PH	NULL
,	NULL
Li-Weber	NULL
M	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
human	NULL
C/EBP	NULL
gamma	NULL
,	NULL
a	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
PRE-I	NULL
enhancer	NULL
element	NULL
of	NULL
the	NULL
human	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Gene	NULL
161:271	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Antonson	NULL
P	NULL
,	NULL
Stellan	NULL
B	NULL
,	NULL
Yamanaka	NULL
R	NULL
,	NULL
Xanthopoulos	NULL
KG	NULL
:	NULL
A	NULL
novel	NULL
human	NULL
CCAAT/enhancer	NULL
binding	NULL
protein	NULL
gene	NULL
,	NULL
C/EBPe	NULL
,	NULL
is	NULL
2993	NULL
expressed	NULL
in	NULL
cells	NULL
of	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
lineages	NULL
and	NULL
is	NULL
localized	NULL
on	NULL
chromosome	NULL
14q11.2	NULL
close	NULL
to	NULL
the	NULL
T-cell	NULL
receptor	NULL
@	NULL
/6	NULL
locus	NULL
.	NULL

Geno-mics	NULL
35:30	NULL
,	NULL
1996	NULL
18	NULL
.	NULL

Chumakov	NULL
AM	NULL
,	NULL
Grillier	NULL
I	NULL
,	NULL
Chumakova	NULL
E	NULL
,	NULL
Chih	NULL
D	NULL
,	NULL
Slater	NULL
J	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
novel	NULL
human	NULL
myeloid-specific	NULL
C/EBP	NULL
transcription	NULL
factor	NULL
(	NULL
C/EBPe	NULL
)	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:1375	NULL
,	NULL
1997	NULL
19	NULL
.	NULL

Shuman	NULL
JD	NULL
,	NULL
Vinson	NULL
CR	NULL
,	NULL
McKnight	NULL
SL	NULL
:	NULL
Evidence	NULL
of	NULL
changes	NULL
in	NULL
protease	NULL
sensitivity	NULL
and	NULL
subunit	NULL
exchange	NULL
rate	NULL
on	NULL
DNA	NULL
binding	NULL
by	NULL
C/EBP	NULL
.	NULL

Science	NULL
249:771	NULL
,	NULL
1990	NULL
20	NULL
.	NULL

Vinson	NULL
CR	NULL
,	NULL
Sigler	NULL
PB	NULL
,	NULL
McKnight	NULL
SL	NULL
:	NULL
Scissors-grips	NULL
model	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
a	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
.	NULL

Science	NULL
246:911	NULL
,	NULL
1989	NULL
21	NULL
.	NULL

Collins	NULL
SJ	NULL
,	NULL
Ruscetti	NULL
FW	NULL
,	NULL
Gallagher	NULL
RE	NULL
,	NULL
Gallo	NULL
RC	NULL
:	NULL
Normal	NULL
functional	NULL
characteristics	NULL
of	NULL
cultured	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
(	NULL
HL-60	NULL
)	NULL
after	NULL
induction	NULL
of	NULL
differentaition	NULL
by	NULL
dimethylsulfoxide	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
149:969	NULL
,	NULL
1979	NULL
22	NULL
.	NULL

Elstner	NULL
E	NULL
,	NULL
Linker-Israeli	NULL
M	NULL
,	NULL
Le	NULL
J	NULL
,	NULL
Grillier	NULL
I	NULL
,	NULL
Said	NULL
J	NULL
,	NULL
Shintaku	NULL
P	NULL
,	NULL
Krajewski	NULL
S	NULL
,	NULL
Reed	NULL
JC	NULL
,	NULL
Binderup	NULL
L	NULL
,	NULL
Koeffler	NULL
HP	NULL
:	NULL
Combination	NULL
of	NULL
potent	NULL
20-epi-vitamin	NULL
D	NULL
;	NULL
,	NULL
analog	NULL
(	NULL
KH1060	NULL
)	NULL
and	NULL
9-cis-retinoic	NULL
acid	NULL
inhibits	NULL
irreversibly	NULL
clonal	NULL
growth	NULL
,	NULL
decreases	NULL
bel-2	NULL
expression	NULL
and	NULL
induces	NULL
apoptosis	NULL
in	NULL
HL-60	NULL
leukemic	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
56:3570	NULL
,	NULL
1996	NULL
23	NULL
.	NULL

Maniatis	NULL
T	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Sambrook	NULL
J	NULL
:	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1989	NULL
24	NULL
.	NULL

Greenberg	NULL
ME	NULL
:	NULL
Identification	NULL
of	NULL
newly	NULL
transcribed	NULL
RNA	NULL
,	NULL
in	NULL
Ausubel	NULL
FM	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Current	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
1988	NULL
,	NULL
p	NULL
4.10.1	NULL
25	NULL
.	NULL

Selsted	NULL
ME	NULL
,	NULL
Miller	NULL
CW	NULL
,	NULL
Novotuy	NULL
MJ	NULL
,	NULL
Morris	NULL
WL	NULL
,	NULL
Koeffier	NULL
HP	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
myeloperoxidase	NULL
deficiency	NULL
shows	NULL
heterogeneous	NULL
patterns	NULL
of	NULL
the	NULL
complete	NULL
deficiency	NULL
state	NULL
manifested	NULL
at	NULL
the	NULL
genomic	NULL
,	NULL
mRNA	NULL
,	NULL
and	NULL
protein	NULL
levels	NULL
.	NULL

Blood	NULL
82:1317	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Chen	NULL
A	NULL
,	NULL
Licht	NULL
JD	NULL
,	NULL
Wu	NULL
Y	NULL
,	NULL
Hellinger	NULL
N	NULL
,	NULL
Scher	NULL
W	NULL
,	NULL
Waxman	NULL
S	NULL
:	NULL
Retinoic	NULL
acid	NULL
is	NULL
required	NULL
for	NULL
and	NULL
potentiates	NULL
differentiation	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
nonretinoid	NULL
agents	NULL
.	NULL

Blood	NULL
84:2122	NULL
,	NULL
1994	NULL
27	NULL
.	NULL

Lanotte	NULL
M	NULL
,	NULL
Martin-Thouvenin	NULL
V	NULL
,	NULL
Najman	NULL
S	NULL
,	NULL
Balerini	NULL
P	NULL
,	NULL
Va-lensi	NULL
F	NULL
,	NULL
Berger	NULL
R	NULL
:	NULL
NB4	NULL
,	NULL
a	NULL
maturation-inducible	NULL
cell	NULL
line	NULL
with	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
marker	NULL
isolated	NULL
from	NULL
a	NULL
humanacute	NULL
promyelocytic	NULL
leukemia	NULL
(	NULL
M3	NULL
)	NULL
.	NULL

Blood	NULL
77:1080	NULL
,	NULL
1991	NULL
28	NULL
.	NULL

Ruchaud	NULL
S	NULL
,	NULL
Duprez	NULL
E	NULL
,	NULL
Gendron	NULL
MC	NULL
,	NULL
Houge	NULL
G	NULL
,	NULL
Genieser	NULL
HG	NULL
,	NULL
Jastorff	NULL
B	NULL
,	NULL
Doskeland	NULL
SO	NULL
,	NULL
Lanotte	NULL
M	NULL
:	NULL
Two	NULL
distinctly	NULL
regulated	NULL
events	NULL
,	NULL
priming	NULL
and	NULL
triggering	NULL
,	NULL
during	NULL
retinoid-induced	NULL
maturation	NULL
and	NULL
resistance	NULL
of	NULL
NB4	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:8428	NULL
,	NULL
1994	NULL
29	NULL
.	NULL

Khana-Gupta	NULL
A	NULL
,	NULL
Kolibaba	NULL
K	NULL
,	NULL
Zibello	NULL
TA	NULL
,	NULL
Berliner	NULL
N	NULL
:	NULL
NB4	NULL
cells	NULL
show	NULL
bilineage	NULL
potential	NULL
and	NULL
an	NULL
aberrant	NULL
pattern	NULL
of	NULL
neutrophil	NULL
secondary	NULL
granule	NULL
protein	NULL
gene	NULL
expression	NULL
.	NULL

Blood	NULL
84:294	NULL
,	NULL
1994	NULL
30	NULL
.	NULL

Bhatia	NULL
M	NULL
,	NULL
Kirkland	NULL
JB	NULL
,	NULL
Meckling-Gill	NULL
KA	NULL
:	NULL
M-CSF	NULL
and	NULL
1,25-dihydroxy	NULL
vitamin	NULL
D	NULL
;	NULL
synergize	NULL
with	NULL
12-O-tetradecanoylphorbal-13-acetate	NULL
to	NULL
induce	NULL
macrophage	NULL
differentiation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
NB4	NULL
cells	NULL
.	NULL

Leukemia	NULL
8:1744	NULL
,	NULL
1994	NULL
31	NULL
.	NULL

Matikainen	NULL
S	NULL
,	NULL
Ronni	NULL
T	NULL
,	NULL
Hurme	NULL
M	NULL
,	NULL
Pine	NULL
R	NULL
,	NULL
Julkunen	NULL
I	NULL
:	NULL
Retinoic	NULL
acid	NULL
activates	NULL
interferon	NULL
regulatory	NULL
factor-1	NULL
gene	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
88:114	NULL
,	NULL
1996	NULL
32	NULL
.	NULL

Olsson	NULL
IL	NULL
,	NULL
Breitman	NULL
TR	NULL
:	NULL
Induction	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
U-937	NULL
by	NULL
retinoic	NULL
acid	NULL
and	NULL
cyclic	NULL
adenosine	NULL
3',5'-monophosphate-inducing	NULL
agents	NULL
.	NULL

Cancer	NULL
Res	NULL
42:3924	NULL
,	NULL
1982	NULL
33	NULL
.	NULL

Morosetti	NULL
R	NULL
,	NULL
Park	NULL
D	NULL
,	NULL
Chumakov	NULL
A	NULL
,	NULL
Shiohara	NULL
M	NULL
,	NULL
Gombart	NULL
A	NULL
,	NULL
Nakamaki	NULL
T	NULL
,	NULL
Weinberg	NULL
K	NULL
,	NULL
Koeffler	NULL
P	NULL
:	NULL
A	NULL
novel	NULL
,	NULL
myeloid-specific	NULL
transcription	NULL
factor	NULL
,	NULL
C/EBPe	NULL
,	NULL
is	NULL
upregulated	NULL
during	NULL
granulocytic	NULL
but	NULL
not	NULL
monocytic	NULL
differentiation	NULL
.	NULL

Blood	NULL
(	NULL
in	NULL
press	NULL
)	NULL
34	NULL
.	NULL

Yamaka	NULL
R	NULL
,	NULL
Kim	NULL
GD	NULL
,	NULL
Radomska	NULL
H	NULL
,	NULL
Lekstrom-Himes	NULL
J	NULL
,	NULL
Smith	NULL
L	NULL
,	NULL
Antonson	NULL
P	NULL
,	NULL
Tenen	NULL
D	NULL
,	NULL
Xanthopoulos	NULL
G	NULL
:	NULL
CCAAT/enhancer	NULL
bind	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2994	NULL
ing	NULL
proteine	NULL
is	NULL
preferentially	NULL
up-regulated	NULL
during	NULL
granulocytic	NULL
differentiation	NULL
and	NULL
its	NULL
functional	NULL
versatility	NULL
is	NULL
determined	NULL
by	NULL
alternative	NULL
use	NULL
of	NULL
promoters	NULL
and	NULL
differential	NULL
splicing	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
94:6462	NULL
,	NULL
1997	NULL
35	NULL
.	NULL

Collins	NULL
SJ	NULL
:	NULL
The	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
:	NULL
Pro-liferation	NULL
,	NULL
differentiation	NULL
and	NULL
cellular	NULL
oncogene	NULL
expression	NULL
.	NULL

Blood	NULL
70:1233	NULL
,	NULL
1987	NULL
36	NULL
.	NULL

Takeuchi	NULL
T	NULL
,	NULL
Nakajima	NULL
M	NULL
,	NULL
Morimoto	NULL
K	NULL
:	NULL
Relationship	NULL
between	NULL
the	NULL
intracellular	NULL
reactive	NULL
oxygen	NULL
species	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
oxida-tive	NULL
DNA	NULL
damage	NULL
in	NULL
human	NULL
neutrophil-like	NULL
cells	NULL
.	NULL

Carcinogenesis	NULL
17:1543	NULL
,	NULL
1996	NULL
37.	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Lanotte	NULL
M	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
(	NULL
15,17	NULL
)	NULL
translocation	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
fuses	NULL
CHIH	NULL
ET	NULL
AL	NULL
the	NULL
retinoic	NULL
acid	NULL
receptor	NULL
a	NULL
gene	NULL
to	NULL
a	NULL
novel	NULL
transcribed	NULL
locus	NULL
.	NULL

Nature	NULL
347:558	NULL
,	NULL
1990	NULL
38	NULL
.	NULL

Borrow	NULL
J	NULL
,	NULL
Goddard	NULL
AD	NULL
,	NULL
Sheer	NULL
D	NULL
,	NULL
Solomon	NULL
E	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
breakpoint	NULL
cluster	NULL
region	NULL
on	NULL
chromosome	NULL
17	NULL
.	NULL

Science	NULL
249:1577	NULL
,	NULL
1990	NULL
39.	NULL
de	NULL
The	NULL
H	NULL
,	NULL
Lavau	NULL
C	NULL
,	NULL
Marchio	NULL
A	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Dejean	NULL
A	NULL
:	NULL
The	NULL
PML-RARa	NULL
fusion	NULL
mRNA	NULL
generated	NULL
by	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
encodes	NULL
a	NULL
functionally	NULL
altered	NULL
RAR	NULL
.	NULL

Cell	NULL
66:675	NULL
,	NULL
1991	NULL
40	NULL
.	NULL

Daniel	NULL
MT	NULL
,	NULL
Koken	NULL
M	NULL
,	NULL
Romagne	NULL
O	NULL
,	NULL
Barbey	NULL
S	NULL
,	NULL
Bazarbachi	NULL
A	NULL
,	NULL
Stadler	NULL
M	NULL
,	NULL
Guillermin	NULL
MC	NULL
,	NULL
Degos	NULL
L	NULL
,	NULL
Chomienne	NULL
C	NULL
,	NULL
de	NULL
The	NULL
H	NULL
:	NULL
PML	NULL
protein	NULL
expression	NULL
in	NULL
hematopoietic	NULL
and	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
82:1858	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1997	NULL
90	NULL
:	NULL
2987-2994	NULL
Modulation	NULL
of	NULL
mRNA	NULL
Expression	NULL
of	NULL
a	NULL
Novel	NULL
Human	NULL
Myeloid-Selective	NULL
CCAAT/Enhancer	NULL
Binding	NULL
Protein	NULL
Gene	NULL
(	NULL
C/EBP	NULL
:	NULL
)	NULL
Doris	NULL
Y.	NULL
Chih	NULL
,	NULL
Alexey	NULL
M.	NULL
Chumakov	NULL
,	NULL
Dorothy	NULL
J	NULL
.	NULL

Park	NULL
,	NULL
Agnes	NULL
G.	NULL
Silla	NULL
and	NULL
H.	NULL
Phillip	NULL
Koeffler	NULL
4	NULL
peRiCAy	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/90/8/2987.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

